{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:13:10Z","timestamp":1775099590452,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajo.2021.06.017","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T11:03:28Z","timestamp":1624964608000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration"],"prefix":"10.1016","volume":"232","author":[{"given":"Arshad M.","family":"Khanani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-8582","authenticated-orcid":false,"given":"Vrinda S.","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dante J.","family":"Pieramici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5198-1353","authenticated-orcid":false,"given":"Rahul N.","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie F.","family":"Maass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee A.","family":"Honigberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Tom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich C.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.06.017_bib0001","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2021.06.017_bib0002","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2021.06.017_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.06.017_bib0004","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2021.06.017_bib0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: Results from the Prospective Proxima A and B Clinical Trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.06.017_bib0006","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ophtha.2009.12.012","article-title":"Progression of geographic atrophy and genotype in age-related macular degeneration","volume":"117","author":"Klein","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.06.017_bib0007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajo.2021.06.017_bib0008","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddy002","article-title":"Genome-wide analysis of disease progression in age-related macular degeneration","volume":"27","author":"Yan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajo.2021.06.017_bib0009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"DeWan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajo.2021.06.017_bib0010","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajo.2021.06.017_bib0011","first-page":"318","article-title":"Specific correlation between the major chromosome 10q26 haplotype conferring risk for age-related macular degeneration and the expression of HTRA1","volume":"23","author":"Liao","year":"2017","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajo.2021.06.017_bib0012","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1097-2765(02)00658-5","article-title":"The HtrA family of proteases: implications for protein composition and cell fate","volume":"10","author":"Clausen","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajo.2021.06.017_bib0013","doi-asserted-by":"crossref","first-page":"e12710","DOI":"10.1111\/acel.12710","article-title":"HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1","volume":"17","author":"Lin","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.ajo.2021.06.017_bib0014","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1073\/pnas.1917608117","article-title":"Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy","volume":"117","author":"Tom","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajo.2021.06.017_bib0015","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1073\/pnas.1102853108","article-title":"Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice","volume":"108","author":"Jones","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajo.2021.06.017_bib0016","doi-asserted-by":"crossref","first-page":"e22959","DOI":"10.1371\/journal.pone.0022959","article-title":"Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components","volume":"6","author":"Vierkotten","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ajo.2021.06.017_bib0017","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","article-title":"Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration","volume":"30","author":"Orozco","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajo.2021.06.017_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20150601","article-title":"The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody","volume":"472","author":"Ciferri","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.ajo.2021.06.017_bib0019","article-title":"Nonclinical safety assessment of FHTR2163, an antigen-binding fragment against HTRA1 for the treatment of geographic atrophy","author":"Dere","year":"2020","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ajo.2021.06.017_bib0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.04-0601","article-title":"Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration","volume":"46","author":"Gaudreault","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.06.017_bib0021","first-page":"595","article-title":"Population pharmacokinetics and pharmacodynamics of lampalizumab administered intravitreally to patients with geographic atrophy","volume":"4","author":"Le","year":"2015","journal-title":"CPT: Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ajo.2021.06.017_bib0022","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/DDDT.S206355","article-title":"Complement system and age-related macular degeneration: drugs and challenges","volume":"13","author":"Wu","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ajo.2021.06.017_bib0023","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 Inhibitor Avacincaptad Pegol for geographic atrophy due to age-related macular degeneration: A randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.06.017_bib0024","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4161\/cc.6.9.4157","article-title":"HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration","volume":"6","author":"Cameron","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajo.2021.06.017_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IAE.0b013e3182979ddd","article-title":"A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy","volume":"34","author":"Do","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2021.06.017_bib0026","doi-asserted-by":"crossref","first-page":"eaaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajo.2021.06.017_bib0027","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:43:05Z","timestamp":1762080185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S0002939421003421"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.06.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}